{"DataElement":{"publicId":"11285801","version":"1","preferredName":"Participant Refusal to Participate Clinical Trial Reason Select","preferredDefinition":"The reason that describes the participant refusal to participate in clinical trial.","longName":"PTCPNT_REF_PRTCPTE_CLINTRL_RSN","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"11284400","version":"1","preferredName":"Participant Refusal to Participate Clinical Trial","preferredDefinition":"Someone who takes part in an activity._Declining to take part in activities or procedures that are available to, or requested or expected of, an individual.:A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.","longName":"11284398v1.00:11284399v1.00","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"11284398","version":"1","preferredName":"Participant Refusal to Participate","preferredDefinition":"Someone who takes part in an activity._Declining to take part in activities or procedures that are available to, or requested or expected of, an individual.","longName":"C29867:C124784","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Participant","conceptCode":"C29867","definition":"Someone who takes part in an activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Refusal to Participate","conceptCode":"C124784","definition":"Declining to take part in activities or procedures that are available to, or requested or expected of, an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9328B32-A80E-0489-E053-731AD00A38C0","latestVersionIndicator":"Yes","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2022-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"11284399","version":"1","preferredName":"Clinical Trial","preferredDefinition":"A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.","longName":"C71104","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial","conceptCode":"C71104","definition":"A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9328B32-A80F-0489-E053-731AD00A38C0","latestVersionIndicator":"Yes","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2022-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9328B32-A810-0489-E053-731AD00A38C0","latestVersionIndicator":"Yes","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2023-06-07","changeDescription":"EAQ201; TL.","administrativeNotes":"06/07/2023-Reviewed and released-MM","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"11284402","version":"1","preferredName":"Reason Select","preferredDefinition":"Select from a group._An explanation of the cause of some phenomenon or action.","longName":"11284402v1.00","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"110","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"I want to wait until there is more evidence before getting a vaccine for cancer protection in\nLynch syndrome.","valueDescription":null,"ValueMeaning":{"publicId":"11284404","version":"1","preferredName":"See More Evidence Prior Cancer Prevention Vaccination Effectiveness For Lynch Syndrome","longName":"11284404v1.00","preferredDefinition":"Perceive by sight._Greater in size, amount, extent, or degree._Knowledge on which to base belief._Earlier in time or order._A vaccination design to provide protection from a type of cancer._The extent to which a diagnostic or therapeutic product achieves its intended effect in the typical clinical setting._The reason of something._An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma. Patients often develop colorectal carcinomas at an early age (mean, 45 years). In the majority of the cases the lesions arise from the proximal colon. At the molecular level, high-frequency microsatellite instability is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"See","conceptCode":"C64647","definition":"Perceive by sight.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"7"},{"longName":"More","conceptCode":"C128667","definition":"Greater in size, amount, extent, or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Evidence","conceptCode":"C43583","definition":"Knowledge on which to base belief.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Cancer Prevention Vaccination","conceptCode":"C63337","definition":"A vaccination design to provide protection from a type of cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Effectiveness","conceptCode":"C142522","definition":"The extent to which a diagnostic or therapeutic product achieves its intended effect in the typical clinical setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lynch Syndrome","conceptCode":"C8494","definition":"An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma. Patients often develop colorectal carcinomas at an early age (mean, 45 years). In the majority of the cases the lesions arise from the proximal colon. At the molecular level, high-frequency microsatellite instability is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9337901-BA73-2F0B-E053-731AD00A9DA9","latestVersionIndicator":"Yes","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"KUMMEROA","dateModified":"2023-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9337901-BA78-2F0B-E053-731AD00A9DA9","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2022-09-21","deletedIndicator":"No"},{"value":"I don’t want to be a “guinea pig.”","valueDescription":null,"ValueMeaning":{"publicId":"11284405","version":"1","preferredName":"Negation Be Guinea Pig","longName":"11284405v1.00","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction._The state or fact of existing at a place and time._The domesticated guinea pig, Cavia porcellus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Be","conceptCode":"C89327","definition":"The state or fact of existing at a place and time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Guinea Pig","conceptCode":"C14211","definition":"The domesticated guinea pig, Cavia porcellus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9337901-BA74-2F0B-E053-731AD00A9DA9","latestVersionIndicator":"Yes","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2022-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9337901-BA79-2F0B-E053-731AD00A9DA9","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2022-09-21","deletedIndicator":"No"},{"value":"I worry about getting side effects from the vaccine.","valueDescription":null,"ValueMeaning":{"publicId":"11284406","version":"1","preferredName":"Worry About Side Effects from Medical Treatments","longName":"11284406v1.00","preferredDefinition":"A question about whether an individual worries about side effects from medical treatments.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Worry About Side Effects from Medical Treatments","conceptCode":"C134923","definition":"A question about whether an individual worries about side effects from medical treatments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9337901-BA75-2F0B-E053-731AD00A9DA9","latestVersionIndicator":"Yes","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2022-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9337901-BA7A-2F0B-E053-731AD00A9DA9","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2022-09-21","deletedIndicator":"No"},{"value":"I don’t trust drug companies (“Big Pharma”).","valueDescription":null,"ValueMeaning":{"publicId":"11284407","version":"1","preferredName":"No Trust Drug Company","longName":"11284407v1.00","preferredDefinition":"The non-affirmative response to a question._Having confidence in the reliability of people or things._A company licensed to discover, develop, market and distribute drugs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Trust","conceptCode":"C71753","definition":"Having confidence in the reliability of people or things.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Drug Company","conceptCode":"C54149","definition":"A company licensed to discover, develop, market and distribute drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9337901-BA76-2F0B-E053-731AD00A9DA9","latestVersionIndicator":"Yes","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2022-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9337901-BA7B-2F0B-E053-731AD00A9DA9","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2022-09-21","deletedIndicator":"No"},{"value":"I worry what a vaccine would do to my immune system.","valueDescription":null,"ValueMeaning":{"publicId":"11284408","version":"1","preferredName":"Worry Vaccine Effect Upon Immune System","longName":"11284408v1.00","preferredDefinition":"Mental distress resulting from concern for something impending or anticipated._Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response._A phenomenon that follows and is caused by some previous phenomenon._Used to indicate that an event is to immediately follow another event._The complex group of organs like thymus, spleen, tonsils, lymphatic system, hematopoetic system and cells like lymphocytes, granulocytes, monocytes and macrophages that defends the body against infection or disease. It consists of a complex interrelated cellular, molecular and genetic component.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Worry","conceptCode":"C86941","definition":"Mental distress resulting from concern for something impending or anticipated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Vaccine","conceptCode":"C923","definition":"Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Effect","conceptCode":"C25492","definition":"A phenomenon that follows and is caused by some previous phenomenon.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Upon","conceptCode":"C65137","definition":"Used to indicate that an event is to immediately follow another event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immune System","conceptCode":"C12735","definition":"The complex group of organs like thymus, spleen, tonsils, lymphatic system, hematopoetic system and cells like lymphocytes, granulocytes, monocytes and macrophages that defends the body against infection or disease. It consists of a complex interrelated cellular, molecular and genetic component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9337901-BA77-2F0B-E053-731AD00A9DA9","latestVersionIndicator":"Yes","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2022-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9337901-BA7C-2F0B-E053-731AD00A9DA9","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2022-09-21","deletedIndicator":"No"},{"value":"I might get cancer even if I take the vaccine","valueDescription":null,"ValueMeaning":{"publicId":"11285800","version":"1","preferredName":"Concerned I Would Develop Symptoms For Cancer Post All Vaccination","longName":"11285800v1.00","preferredDefinition":"The individual was concerned they would develop symptoms._The reason of something._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._Happening at a time subsequent to a reference time; later in time or order._To a complete degree or to the full or entire extent._Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis or treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concerned I Would Develop Symptoms","conceptCode":"C107526","definition":"The individual was concerned they would develop symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"All","conceptCode":"C64916","definition":"To a complete degree or to the full or entire extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Vaccination","conceptCode":"C15346","definition":"Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis or treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E93449D3-0244-4CDD-E053-731AD00ACF7E","latestVersionIndicator":"Yes","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2022-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E93449D3-0245-4CDD-E053-731AD00ACF7E","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2022-09-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"11284401","version":"1","preferredName":"Choose Reason","preferredDefinition":"Select from a group._An explanation of the cause of some phenomenon or action.","longName":"11284401v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choose","conceptCode":"C48912","definition":"Select from a group.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E932AE0D-0594-1168-E053-731AD00A36A2","latestVersionIndicator":"Yes","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2022-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E932AE0D-0595-1168-E053-731AD00A36A2","latestVersionIndicator":"Yes","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"KUMMEROA","dateModified":"2023-09-21","changeDescription":null,"administrativeNotes":"2023.9.21 Updated PV def for 'No Value Exists'  ak 06/20/2023- Released upon review-MM","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Got it, thank you. Before you go, would you let us know your reasons for not being in the\ntrial? For example, some people say (read first item). Does that apply to you? How about\n(read second item)? Just a couple more (finish list).","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9347F52-7DBC-5320-E053-731AD00AFF23","latestVersionIndicator":"Yes","beginDate":"2022-09-21","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-09-21","modifiedBy":"MMADDINENI","dateModified":"2023-06-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}